account(Reuters) ��� A jury began deliberating on whether Abbott Laboratories should pay GlaxoSmithKline hundreds of millions of dollars over allegations of unfair HIV drug pricing. Lawyers for the two pharmaceutical companies made closing arguments on Thursday...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Jury gets suit against Abbott over HIV drug pricing
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account